Explore evidence

1.64 %The prevalence of sickle cell disease (SCD) among 3648 newborns in Mali was 1.64% (95% CI: 1.23–2.06).

Malidrépanocytoseobserved April–August 2021HAL · Unilimdocument of 103 observations

33,160 casesFrom January 3, 2020, to November 22, 2023, 33,160 confirmed cases of COVID-19 have been reported in Mali.

MaliCOVID-19observed January 3, 2020 to November 22, 2023HAL · Unilimdocument of 88 observations

612 patients612 sickle cell disease patients and 149 healthy controls were included in the CADRE study in Cameroon, Mali, and Senegal.

Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument of 2 observations

12 %In 2017, the combined intervention of seasonal RTS,S/AS01 E malaria vaccination with seasonal malaria chemoprevention (SMC) reduced the prevalence of wasting by approximately 12% compared to SMC alone.

Burkina Faso · Malipaludismeobserved 2017published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04077-x

820.6 per_1000_person_yearsThe highest malaria incidence (820.6 cases per 1,000 person-years) was recorded in the health district of Yorosso (Sikasso region in the south) in the year 2019–2020.

Malipaludismeobserved 2019–2020HAL · Unilimdocument of 111 observations

70.11 %70,11 % des participants âgés de 65 ans et plus avaient des densités parasitaires faibles (1 à 2500 parasites/μL), avec un intervalle de confiance à 95 % de 59,53 à 80,78 %.

MalipaludismeHAL · Unilimdocument of 214 observations

0.15 hazard_ratioIn a cohort study in Bandiagara, Mali, from June 2009 to June 2010, hemoglobin AS children had a hazard ratio of 0.15 for first clinical malaria episode compared to hemoglobin AA children.

Malipaludismeobserved June 2009 to June 2010published 2015The Journal of infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1093/infdis/jiv308

255.5 per_1000_person_yearsThe median malaria incidence went from 255.5 cases per 1,000 person-years in the first epidemic year (2017–2018) to 325.2 cases per 1,000 person-years in the last epidemic year (2021–2022).

Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations

99.67 %The specificity of HemotypeSC® for detecting sickle cell disease was 99.67% (95% CI: 99.48–99.85).

MalidrépanocytoseHAL · Unilimdocument of 103 observations

6 %On day 28, the rate of recurrent parasitemia in the Artemether-lumefantrine (AL) arm was 6.0% in patients with neutrophilia.

Malipaludismeobserved day 28published 2023Journal of infection in developing countrieseurope_pmcdocument of 4 observationsDOI 10.3855/jidc.17089

81.6 %The prevalence of the Pfcrt-76T genotype was 81.6% in Kolle and 38.6% in Bandiagara.

Malipaludismepublished 2023Cytokineeurope_pmcdocument of 3 observations

98.66 %The negative predictive value (NPV) of HemotypeSC® for detecting sickle cell trait was 98.66% (95% CI: 98.24–99.03).

Malitrait drépanocytaireHAL · Unilimdocument of 103 observations

0.005 p_valueScores in the United States were higher than in Mali for questionnaires assessing understanding of informed consent for malaria vaccine trials, with a p-value of 0.005.

Malipaludismepublished 2010American Journal of Tropical Medicine and HygieneOpenAlexdocument of 3 observationsDOI 10.4269/ajtmh.2010.10-0062

11.29 %Au Mali, la proportion de faible poids de naissance est passée de 11,29 % en 2020 à 7,6 % en 2023.

Malifaible poids de naissanceobserved 2020HAL · Unilimdocument of 302 observations

3,200 pf/microlThe cut-off value for pyrogenic threshold of Plasmodium falciparum parasitaemia was around 3200 pf/microl during the rainy season in Bandiagara district, Mali.

Malipaludismeobserved rainy season of 1993published 2005Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x

200,000,000 casesMore than 200 million cases and over 4 million deaths have been reported worldwide for COVID-19.

MaliCOVID-19HAL · Unilimdocument of 67 observations

49.5 %The national average coverage of intermittent preventive treatment during pregnancy (IPTp) in Mali was 49.5%.

MalipaludismeHAL · Unilimdocument of 95 observations

97 %Plasmodium falciparum constitutes 97 percent of malaria cases in Mali.

MalipaludismeHAL · Unilimdocument of 95 observations

80 %In Mali, 25 out of 31 health districts with high malaria transmission received dual active ingredient (dual AI) long-lasting insecticidal nets (LLINs), representing 80% of high-transmission districts.

MalipaludismeHAL · Unilimdocument of 95 observations

22,295 casesThe expected total number of SARS-CoV-2 infections in the population of Tombouctou (70,000 inhabitants) from the start of the epidemic until January 2021 was 22,295 cases.

MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations

10 %Dans les zones de savane sèche comme le centre du Mali, les taux de prévalence de P. malariae dépassent rarement 10 %.

MalipaludismeHAL · Unilimdocument of 214 observations

65.2 %La prévalence du paludisme due à toutes les espèces de Plasmodium était de 65,20 % lors du dépistage passif dans la commune rurale de Ntjiba, Mali, entre 2016 et 2021.

Malipaludismeobserved 2016 à 2021HAL · Unilimdocument of 214 observations

12.2 per_1000_person_yearsThe lowest malaria incidence (12.2 cases per 1,000 person-years) was observed in the health district of Al-Ourche (Taoudenni region in the north) in the year 2017–2018.

Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations

The Plasmodium PI4K-specific inhibitor KDU691 is highly inhibitory against Plasmodium malariae and Plasmodium falciparum.

Malipaludismepublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 4 observations

10 %After the LLINs distribution campaign in 2023, the number of malaria cases fell by 10%, something that had not happened since 2017.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations